Epidemiology of primary sclerosing cholangitis among patients with inflammatory bowel disease in Asian countries: An international multicenter retrospective study

Epidemiology of primary sclerosing cholangitis among patients with inflammatory bowel disease in Asian countries: An international multicenter retrospective study - PSC-IBD in Asia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054487

Enrollment

300

Registered

2024-06-01

Start date

2023-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 16 years of age and more than 16 yeas of age Diagnosis of IBD (Ulcerative colitis or Crohn's disease) confirmed until the end date of this study Diagnosis of PSC confirmed until the end date of this study

Exclusion criteria

Exclusion criteria: Patients who have expressed their unwillingness to participate

Design outcomes

Primary

Measure	Time frame
The incidence of PSC among Asian patients with IBD	—

Secondary

Measure	Time frame
The risks of hospitalization, surgery (total colectomy and liver transplantation), and colorectal cancer in PSC-IBD will be assessed. We also evaluate endoscopic characteristics (e.g. disease locations and endoscopic severity) as well as other imaging, pathological, and biochemical findings related to intestinal and/or biliary diseases in PSC-IBD patients.	—

Countries

Japan,Asia(except Japan)

Contacts

Public ContactShintaro Akiyama

Institute of Medicine, University of Tsukuba Department of Gastroenterology

akiyama@md.tsukuba.ac.jp029-853-3218

Outcome results